StonvexLoading…
StonvexStonvexStonvexCore line items from TAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-02-28 | Annual 2024 2024-02-29 | Annual 2023 2023-02-28 | Annual 2022 2022-02-28 |
|---|---|---|---|---|
Revenue | $2.25B | $1.49B | $1.02B | $4.39B |
Operating Income | $-3.15M | $-69.23M | $-90.73M | $-614.52M |
Net Income | $84.59M | $-3.57M | $-135.61M | $-1.14B |
EPS (Diluted) | $0.41 | $-0.02 | $-0.64 | $-5.29 |
Total Assets | $5.50B | $4.93B | $4.72B | $5.08B |
Total Liabilities | $1.74B | $1.29B | $903.44M | $1.08B |
Cash & Equivalents | $1.77B | $2.21B | $2.02B | $1.64B |
Free Cash Flow OCF − CapEx | $286.19M | $193.44M | $-102.97M | $-1.19B |
Shares Outstanding | 205.22M | 203.30M | 212.58M | 214.83M |